Neuroimaging of drug resistance in epilepsy

Current Opinion in Neurology

Volumn 27, Issue 2, 2014, Pages 192-198

  Koepp, Matthias J ^a,b  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b EPILEPSY SOCIETY   (United Kingdom)

Author keywords

connectivity; functional MRI; MRI; PET

Indexed keywords

ANTICONVULSIVE AGENT; CARBON 11; ELACRIDAR; FLUMAZENIL; FLUORINE 18; LANIQUIDAR; MULTIDRUG RESISTANCE PROTEIN; N DESMETHYLLOPERAMIDE C 11; N METHYLTRYPTOPHAN; TARIQUIDAR; TOPIRAMATE; TRACER; UNCLASSIFIED DRUG; VALPROIC ACID; VERAPAMIL;

ANTICONVULSANT THERAPY; BENIGN CHILDHOOD EPILEPSY; CHRONIC DISEASE; COGNITION; COGNITIVE DEFECT; EPILEPSY; EPILEPTIC STATE; EPILEPTOGENESIS; FOCAL EPILEPSY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HEMISPHERE; HEMISPHERIC DOMINANCE; HUMAN; LANGUAGE; LENNOX GASTAUT SYNDROME; META ANALYSIS (TOPIC); MOLECULAR IMAGING; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT COUNSELING; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE PERIOD; PREDICTION; PROGNOSIS; PYRIFORM CORTEX; REVIEW; ROLANDIC EPILEPSY; SEIZURE; SEVERE MYOCLONIC EPILEPSY IN INFANCY; SINGLE DRUG DOSE; TEMPORAL LOBECTOMY; TREATMENT RESPONSE; WEST SYNDROME;

AMOBARBITAL; BRAIN; EPILEPSY; HUMANS; NEUROIMAGING; TREATMENT OUTCOME;

EID: 84896400196     PISSN: 13507540     EISSN: 14736551     Source Type: Journal    
DOI: 10.1097/WCO.0000000000000072     Document Type: Review

References (53)

1. Engel J Jr, Thompson PM, Stern JM, et al. Connectomics and epilepsy. Curr Opin Neurol 2013; 26:186-194.
2. Bernhardt BC, Hong SJ, Bernasconi A, Bernasconi N. Imaging structural and functional brain networks in temporal lobe epilepsy. Front Hum Neurosci 2013; 7:624.
3. Bonilha L, Tabesh A, Dabbs K, et al. Neurodevelopmental alterations of largescale structural networks in children with new-onset epilepsy. Hum Brain Mapp 2014. [Epub ahead of print]
4. Voets NL, Beckmann CF, Cole DM, et al. Structural substrates for resting network disruption in temporal lobe epilepsy. Brain 2012; 135 (Pt 8):2350-2357.
5. Fahoum F, Zelmann R, Tyvaert L, et al. Epileptic discharges affect the default mode network: fMRI and intracerebral EEG evidence. PLoS ONE 2013; 8:e68038.
6. Flanagan D, Badawy RA, Jackson GD. EEG-fMRI in focal epilepsy: local activation and regional networks. Clin Neurophysiol 2014; 125:21-31.
7. Laufs H, Richardson MP, Salek-Haddadi A, et al. Converging PET and fMRI evidence for a common area involved in human focal epilepsies. Neurology 2011; 77:904-910.
8. Kelly C, Biswal BB, Craddock RC, et al. Characterizing variation in the functional connectome: promise and pitfalls. Trends Cogn Sci 2012; 16: 181-188.
9. Braakman HM, Vaessen MJ, Jansen JF, et al. Frontal lobe connectivity and cognitive impairment in pediatric frontal lobe epilepsy. Epilepsia 2013; 54: 446-454.
10. Zhang Z, Liao W, Wang Z, et al. Epileptic discharges specifically affect intrinsic connectivity networks during absence seizures. J Neurol Sci 2014; 336:138-145.
11. Chaudhary UJ, Carmichael DW, Rodionov R, et al. Mapping preictal and ictal haemodynamic networks using video-electroencephalography and functional imaging. Brain 2012; 135 (Pt 12):3645-3646.
12. Moeller F, Stephani U, Siniatchkin M. Simultaneous EEG and fMRI recordings (EEG-fMRI) in children with epilepsy. Epilepsia 2013; 54:971-982.
13. Pillay N, Archer JS, Badawy RA, et al. Networks underlying paroxysmal fast activity and slow spike and wave in Lennox-Gastaut syndrome. Neurology 2013; 81:665-673.
14. Japaridze N, Muthuraman M, Moeller F, et al. Neuronal networks in West syndrome as revealed by source analysis and renormalized partial directed coherence. Brain Topogr 2013; 26:157-170.
15. Moehring J, von Spiczak S, Moeller F, et al. Variability of EEG-fMRI findings in patients with SCN1A-positive Dravet syndrome. Epilepsia 2013; 54:918-926.
16. Besseling RM, Overvliet GM, Jansen JF, et al. Aberrant functional connectivity between motor and language networks in rolandic epilepsy. Epilepsy Res 2013; 107:253-262.
17. Moeller F, Moehring J, Ick I, et al. EEG-fMRI in atypical benign partial epilepsy. Epilepsia 2013; 54:e103-e108.
18. Tsai MH, Pardoe HR, Perchyonok Y, et al. Etiology of hippocampal sclerosis: evidence for a predisposing familial morphologic anomaly. Neurology 2013; 81:144-149.
19. Berl MM, Zimmaro LA, Khan OI, et al. Characterization of atypical language activation patterns in focal epilepsy. Ann Neurol 2013. [Epub ahead of print]
20. Janecek JK, Swanson SJ, Sabsevitz DS, et al. Language lateralization by fMRI and Wada testing in 229 patients with epilepsy: rates and predictors of discordance. Epilepsia 2013; 54:314-322.
21. Bauer PR, Reitsma JB, Houweling BM, et al. Can fMRI safely replace the Wada test for preoperative assessment of language lateralisation? A meta-analysis and systematic review. Neurol Neurosurg Psychiatry 2013. [Epub ahead of print]
22. Pahs G, Rankin P, Helen Cross J, et al. Asymmetry of planum temporale constrains interhemispheric language plasticity in children with focal epilepsy. Brain 2013; 136 (Pt 10):3163-3175.
23. Sidhu MK, Stretton J, Winston GP, et al. A functional magnetic resonance imaging study mapping the episodic memory encoding network in temporal lobe epilepsy. Brain 2013; 136 (Pt 6):1868-1888.
24. Stretton J, Winston GP, Sidhu M, et al. Disrupted segregation of working memory networks in temporal lobe epilepsy. Neuroimage Clin 2013; 2:273-281.
25. Campo P, Poch C, Toledano R, et al. Anterobasal temporal lobe lesions alter recurrent functional connectivity within the ventral pathway during naming. J Neurosci 2013; 33:12679-12688.
26. Janecek JK, Swanson SJ, Sabsevitz DS, et al. Naming outcome prediction in patients with discordant Wada and fMRI language lateralization. Epilepsy Behav 2013; 27:399-403.
27. Rosazza C, Ghielmetti F, Minati L, et al. Preoperative language lateralization in temporal lobe epilepsy (TLE) predicts peri-ictal, pre and postoperative language performance: an fMRI study. Neuroimage Clin 2013; 3:73-83.
28. Croft LJ, Rankin PM, Liégeois F, et al. To speak, or not to speak? The feasibility of imaging overt speech in children with epilepsy. Epilepsy Res 2013; 107:195-199.
29. Willment KC, Golby A. Hemispheric lateralization interrupted: material-specific memory deficits in temporal lobe epilepsy. Front Hum Neurosci 2013; 7:546.
30. Bonelli SB, Powell RH, Yogarajah M, et al. Imaging memory in temporal lobe epilepsy: predicting the effects of temporal lobe resection. Brain 2010; 133 (Pt 4):1186-1199.
31. Bonelli SB, Thompson PJ, Yogarajah M, et al. Memory reorganization following anterior temporal lobe resection: a longitudinal functional MRI study. Brain 2013; 136 (Pt 6):1889-1900.
32. Bigras C, Shear PK, Vannest J, et al. The effects of temporal lobe epilepsy on scene encoding. Epilepsy Behav 2013; 26:11-21.
33. Yasuda CL, Centeno M, Vollmar C, et al. The effect of topiramate on cognitive fMRI. Epilepsy Res 2013; 105:250-255.
34. Szaflarski JP, Kay B, Gotman J, et al. The relationship between the localization of the generalized spike and wave discharge generators and the response to valproate. Epilepsia 2013; 54:471-480.
35. Pardoe HR, Berg AT, Jackson GD. Sodium valproate use is associated with reduced parietal lobe thickness and brain volume. Neurology 2013; 80:1895-1900.
36. Farwell MD, Chong DJ, Iida Y, et al. Imaging P-glycoprotein function in rats using [(11)C]-N-desmethyl-loperamide. Ann Nucl Med 2013; 27:618-624.
37. Syvänen S, Russmann V, Verbeek J, et al. [11C]quinidine and [11C]laniquidar PET imaging in a chronic rodent epilepsy model: impact of epilepsy and drug-responsiveness. Nucl Med Biol 2013; 40:764-775.
38. Bauer M, Karch R, Zeitlinger M, et al. Interaction of 11C-tariquidar and 11C-elacridar with P-glycoprotein and breast cancer resistance protein at the human blood-brain barrier. J Nucl Med 2013; 54:1181-1187.
39. Römermann K, Wanek T, Bankstahl M, et al. (R)-[(11)C]verapamil is selectively transported by murine and human P-glycoprotein at the blood-brain barrier, and not by MRP1 and BCRP. Nucl Med Biol 2013; 40:873-878.
40. Syvänen S, Labots M, Tagawa Y, et al. Altered GABAA receptor density and unaltered blood-brain barrier transport in a kainate model of epilepsy: an in vivo study using 11C-flumazenil and PET. J Nucl Med 2012; 53:1974-1983.
41. Bauer M, Zeitlinger M, Karch R, et al. Pgp-mediated interaction between (R)-[11C]verapamil and tariquidar at the human blood-brain barrier: a comparison with rat data. Clin Pharmacol Ther 2012; 91:227-233.
42. Feldmann M, Asselin MC, Liu J, et al. P-glycoprotein expression and function in patients with temporal lobe epilepsy: a case-control study. Lancet Neurol 2013; 12:777-785.
43. Harroud A, Bouthillier A, Weil AG, Nguyen DK. Temporal lobe epilepsy surgery failures: a review. Epilepsy Res Treat 2012; 2012:201651.
44. Bernhardt BC, Kim H, Bernasconi N. Patterns of subregional mesiotemporal disease progression in temporal lobe epilepsy. Neurology 2013; 81:1840-1847.
45. Bonilha L, Helpern JA, Sainju R, et al. Presurgical connectome and post-surgical seizure control in temporal lobe epilepsy. Neurology 2013; 81: 1704-1710.
46. Vivash L, Gregoire MC, Lau EW, et al. 18F-flumazenil: a g-aminobutyric acid A-specific PET radiotracer for the localization of drug-resistant temporal lobe epilepsy. J Nucl Med 2013; 54:1270-1277.
47. Chugani HT, Luat AF, Kumar A, et al. a-[11C]-Methyl-L-tryptophan: PET in 191 patients with tuberous sclerosis complex. Neurology 2013; 81:674-680.
48. Juhász C, Buth A, Chugani DC, et al. Successful surgical treatment of an inflammatory lesion associated with new-onset refractory status epilepticus. Neurosurg Focus 2013; 34:E5.
49. Martinez A, Finegersh A, Cannon DM, et al. The 5-HT1A receptor and 5-HT transporter in temporal lobe epilepsy. Neurology 2013; 80:1465-1471.
50. Pan JW, Duckrow RB, Gerrard J, et al. 7T MR spectroscopic imaging in the localization of surgical epilepsy. Epilepsia 2013; 54:1668-1678.
51. Jung J, Bouet R, Delpuech C, et al. The value of magnetoencephalography for seizure-onset zone localization in magnetic resonance imaging-negative partial epilepsy. Brain 2013; 136 (Pt 10):3176-3186.
52. Wilenius J, Medvedovsky M, Gaily E, et al. Interictal MEG reveals focal cortical dysplasias: special focus on patients with no visible MRI lesions. Epilepsy Res 2013; 105:337-348.
53. Kim H, Kankirawatana P, Killen J, et al. Magnetic source imaging (MSI) in children with neocortical epilepsy: surgical outcome association with 3D postresection analysis. Epilepsy Res 2013; 106:164-172.